Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 8
Submit an article Journal homepage
168
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemia

Petro E Petrides Hematology Oncology Center, Zweibruckenstr. 2, 80331 Munich, Germany. [email protected]
Pages 1781-1798 | Published online: 25 Feb 2005

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Carles Besses. (2013) Anagrelide hydrochloride for essential thrombocythemia. Expert Opinion on Orphan Drugs 1:12, pages 1049-1062.
Read now
Gunnar Birgegård. (2013) Pharmacological management of essential thrombocythemia. Expert Opinion on Pharmacotherapy 14:10, pages 1295-1306.
Read now

Articles from other publishers (15)

Nicholas A. Meanwell. (2023) Anagrelide: A Clinically Effective cAMP Phosphodiesterase 3A Inhibitor with Molecular Glue Properties. ACS Medicinal Chemistry Letters 14:4, pages 350-361.
Crossref
Petro E. Petrides, Christian Schoergenhofer, Rudolf Widmann, Bernd Jilma & Christoph S. Klade. (2018) Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product. Clinical Pharmacology in Drug Development 7:2, pages 123-131.
Crossref
Gee Chuan Wong. (2011) Should Chemotherapy Be Administered for Essential Thrombocythemia (ET) Patients with Leukemic Transformation?. Proceedings of Singapore Healthcare 20:1, pages 41-47.
Crossref
Petro E. Petrides, Heinz Gisslinger, Michael Steurer, Werner Linkesch, Günther Krumpl, Agnes Schüller & Rudolf Widmann. (2009) Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation. Clinical Therapeutics 31:2, pages 386-398.
Crossref
Gunnar Birgegård. (2008) Long-term management of thrombocytosis in essential thrombocythaemia. Annals of Hematology 88:1, pages 1-10.
Crossref
Brigitta Marson & Claire Harrison. (2007) Controversies in the Management of Essential Thrombocythemia. Clinical Leukemia 1:3, pages 155-161.
Crossref
Craig M. Kessler & Jan Jacques Michiels. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis 295 318 .
J. Thiele, H.M. Kvasnicka & J. Vardiman. (2006) Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: A forgotten pearl. Best Practice & Research Clinical Haematology 19:3, pages 413-437.
Crossref
Y Hong, G Wang, A Gutierrez del Arroyo, J Hernandez, C Skene & J D Erusalimsky. (2006) Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineage. Leukemia 20:6, pages 1117-1122.
Crossref
Petro E. Petrides & Fabian Siegel. (2006) Thrombotic complications in essential thrombocythemia (ET): Clinical facts and biochemical riddles. Blood Cells, Molecules, and Diseases 36:3, pages 379-384.
Crossref
Claire N Harrison. (2005) Anagrelide for control of thrombocytosis due to myeloproliferative disorders. Future Oncology 1:5, pages 609-618.
Crossref
Guido Finazzi & Claire Harrison. (2005) Essential Thrombocythemia. Seminars in Hematology 42:4, pages 230-238.
Crossref
Z. Zhu, R. Gonthier & L. Neirinck. (2005) High-performance liquid chromatography–mass spectrometry method for determination of anagrelide in human plasma. Journal of Chromatography B 822:1-2, pages 238-243.
Crossref
Claire N. Harrison. (2005) Essential thrombocythaemia: challenges and evidence-based management. British Journal of Haematology 130:2, pages 153-165.
Crossref
Petro E. Petrides. 2004. Molecular Basis of Chronic Myeloproliferative Disorders. Molecular Basis of Chronic Myeloproliferative Disorders 124 130 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.